Your browser doesn't support javascript.
loading
Eplerenone prevented obesity-induced inflammasome activation and glucose intolerance.
Wada, Tsutomu; Ishikawa, Akari; Watanabe, Eri; Nakamura, Yuto; Aruga, Yusuke; Hasegawa, Hayate; Onogi, Yasuhiro; Honda, Hiroe; Nagai, Yoshinori; Takatsu, Kiyoshi; Ishii, Yoko; Sasahara, Masakiyo; Koya, Daisuke; Tsuneki, Hiroshi; Sasaoka, Toshiyasu.
Afiliación
  • Wada T; Department of Clinical PharmacologyUniversity of Toyama, Toyama, Japan tsasaoka@pha.u-toyama.ac.jp twada@pha.u-toyama.ac.jp.
  • Ishikawa A; Department of Clinical PharmacologyUniversity of Toyama, Toyama, Japan.
  • Watanabe E; Department of Clinical PharmacologyUniversity of Toyama, Toyama, Japan.
  • Nakamura Y; Department of Clinical PharmacologyUniversity of Toyama, Toyama, Japan.
  • Aruga Y; Department of Clinical PharmacologyUniversity of Toyama, Toyama, Japan.
  • Hasegawa H; Department of Clinical PharmacologyUniversity of Toyama, Toyama, Japan.
  • Onogi Y; Department of Clinical PharmacologyUniversity of Toyama, Toyama, Japan.
  • Honda H; Department of Immunobiology and Pharmacological GeneticsUniversity of Toyama, Toyama, Japan.
  • Nagai Y; Toyama Prefectural Institute for Pharmaceutical ResearchToyama, Japan.
  • Takatsu K; Department of Immunobiology and Pharmacological GeneticsUniversity of Toyama, Toyama, Japan.
  • Ishii Y; JSTPRESTO, Saitama, Japan.
  • Sasahara M; Department of Immunobiology and Pharmacological GeneticsUniversity of Toyama, Toyama, Japan.
  • Koya D; Toyama Prefectural Institute for Pharmaceutical ResearchToyama, Japan.
  • Tsuneki H; Department of PathologyUniversity of Toyama, Toyama, Japan.
  • Sasaoka T; Department of PathologyUniversity of Toyama, Toyama, Japan.
J Endocrinol ; 235(3): 179-191, 2017 Dec.
Article en En | MEDLINE | ID: mdl-28855315
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Espironolactona / Intolerancia a la Glucosa / Antagonistas de Receptores de Mineralocorticoides / Inflamación / Obesidad Tipo de estudio: Etiology_studies Límite: Animals Idioma: En Revista: J Endocrinol Año: 2017 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Espironolactona / Intolerancia a la Glucosa / Antagonistas de Receptores de Mineralocorticoides / Inflamación / Obesidad Tipo de estudio: Etiology_studies Límite: Animals Idioma: En Revista: J Endocrinol Año: 2017 Tipo del documento: Article